Decoding Dementia: Dr. Emma Mead on the Future of Alzheimer’s Therapies

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to basket failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from Wish List failed.

Please try again later

Follow podcast failed

Unfollow podcast failed

Decoding Dementia: Dr. Emma Mead on the Future of Alzheimer’s Therapies

Listen for free

View show details

About this listen

Dr. Emma Mead is the Chief Scientific Officer at the Oxford Drug Discovery Institute. In this episode, we explore with her the cutting-edge science behind Alzheimer’s and other neurodegenerative diseases.

Dr. Mead takes us through the journey from groundbreaking genetic discoveries to the development of potential therapies, explaining how tiny brain cells called microglia could hold the key to preventing and slowing dementia.

We dive into the complexities of Alzheimer’s beyond amyloid plaques, the promise of targeting genes like PLCG2, and the innovative approaches to drug discovery—from identifying molecular “hits” in the lab to partnering with pharmaceutical companies for clinical trials. Emma also shares her vision for a future where patients benefit from a toolbox of personalised treatments, early diagnosis, and improved quality of life.

This episode offers hope, insight, and a human perspective on a disease that affects one in two of us, directly or indirectly. Whether you’re a researcher, carer, or someone interested in the future of neuroscience, this conversation highlights why the next decade could transform dementia care.

If you have any questions for Justine and Prof Julie. Email us hello@twomindspodcast.co.uk.

For further help and advice please visit
https://www.alzheimers.org.uk.

No reviews yet